Research & Development
US FDA accepts IND application for AskBio's AB-1009
15 January 2026 - Gene therapy specialist AskBio Inc, a wholly owned and independently operated subsidiary of German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY), announced...
EspeRare and n-Lorem partner to expand European access to ASO therapies for rare genetic diseases
14 January 2026 - Non-profit organisations the EspeRare Foundation, based in Switzerland, and US-based n-Lorem Foundation on Wednesday announced a strategic collaboration to expand access in Europe to...
Bionpharma and STEERLife's Etravirine tablets approved by US FDA
14 January 2026 - STEERLife, the life sciences division of India-based STEER World, and Bionpharma Inc, a US-based pharmaceutical company, announced on Tuesday that Bionpharma has received Abbreviated...
Kestra partners with Biobeat to add cuffless blood pressure monitoring to wearable defibrillator
13 January 2026 - Kestra Medical Technologies, Ltd. (NASDAQ: KMTS), a US-based wearable medical device and digital healthcare company, announced on Tuesday that it has entered a strategic collaboratio...
argenx secures FDA priority review for VYVGART in seronegative myasthenia gravis
13 January 2026 - European immunology company argenx SE (EBR & NASDAQ: ARGX) said on Tuesday that the US Food and Drug Administration has accepted for priority review a supplemental Biologics Lice...
Abbisko Therapeutics reports US FDA acceptance of pimicotinib NDA
13 January 2026 - Abbisko Therapeutics Co Ltd (HKEX:02256), a China-based, oncology-focused biopharmaceutical company, announced on Monday that the US Food and Drug Administration (FDA) has accepted t...